DEA Restricts Imports of Synthetic Cannabinoids
12 July 2018
The U.S. Drug Enforcement Administration has announced its intent to issue an order temporarily including the following synthetic cannabinoids (and their optical, positional and geometric isomers, salts and salts of isomers) into schedule I of the Controlled Substances Act. The temporary scheduling order has the effect of imposing the regulatory requirements under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of these substances, as well as the administrative, civil and criminal penalties that apply to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.
This order will be effective on 10 July and remain in place for two years, with a possible extension of one year. Affected products are:
- naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
- methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate
- North America